HUE041329T2 - Támogatott részecskeméret-csökkentési eljárás - Google Patents
Támogatott részecskeméret-csökkentési eljárásInfo
- Publication number
- HUE041329T2 HUE041329T2 HUE15702834A HUE15702834A HUE041329T2 HU E041329 T2 HUE041329 T2 HU E041329T2 HU E15702834 A HUE15702834 A HU E15702834A HU E15702834 A HUE15702834 A HU E15702834A HU E041329 T2 HUE041329 T2 HU E041329T2
- Authority
- HU
- Hungary
- Prior art keywords
- particle size
- reduction process
- size reduction
- assisted particle
- assisted
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 238000010951 particle size reduction Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Thermistors And Varistors (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT10743314A PT107433B (pt) | 2014-01-28 | 2014-01-28 | Processo de redução e controlo do tamanho de partícula |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE041329T2 true HUE041329T2 (hu) | 2019-05-28 |
Family
ID=52450514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE15702834A HUE041329T2 (hu) | 2014-01-28 | 2015-01-27 | Támogatott részecskeméret-csökkentési eljárás |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10328027B2 (enExample) |
| EP (1) | EP3096738B1 (enExample) |
| JP (1) | JP6499187B2 (enExample) |
| AU (1) | AU2015212618B2 (enExample) |
| CA (1) | CA2938071A1 (enExample) |
| DK (1) | DK3096738T3 (enExample) |
| ES (1) | ES2702643T3 (enExample) |
| HU (1) | HUE041329T2 (enExample) |
| IL (1) | IL246989A0 (enExample) |
| PT (1) | PT107433B (enExample) |
| WO (1) | WO2015114320A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060140984A1 (en) | 2002-10-25 | 2006-06-29 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| AU2010302350B2 (en) | 2009-10-02 | 2015-06-18 | Journey Medical Corporation | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US12661407B2 (en) | 2010-04-08 | 2026-06-23 | Journey Medical Corporation | Compositions, gels and foams with rheology modulators and uses thereof |
| PT108368B (pt) | 2015-03-31 | 2018-11-05 | Hovione Farm S A | Produção contínua de partículas |
| PT109117B (pt) * | 2016-01-28 | 2019-02-01 | Hovione Farm Sa | Complexação de ingredientes ativos farmacêuticos |
| IL285928B2 (en) | 2016-05-06 | 2025-06-01 | Eagle Pharmaceuticals Inc | Fulvestrant formulations and methods of their use |
| MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
| CN110361307B (zh) * | 2019-08-15 | 2022-04-01 | 安徽工程大学 | 一种利用粒度分布特征值判断稻米新陈度的方法 |
| GB202002325D0 (en) | 2020-02-19 | 2020-04-01 | Univ Limerick | Particle coating method |
| EP3868842B1 (en) | 2020-02-19 | 2023-06-07 | University of Limerick | Particle coating method |
| US12485133B2 (en) | 2021-02-04 | 2025-12-02 | Hovione Scientia Limited | Inhaled ivermectin |
| CA3221280A1 (en) | 2021-06-03 | 2022-12-08 | Arcadia Medicine, Inc. | Enantiomeric entactogen compositions and methods of their use |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0008411D0 (en) * | 2000-04-05 | 2000-05-24 | Vectura Ltd | Pharmaceutical preparations and their manufacture |
| GB0016040D0 (en) | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
| US6379459B1 (en) * | 2000-10-24 | 2002-04-30 | The United States Of America As Represented By The Secretary Of The Interior | Crystallization of powders having uniform particle sizes by Ostwald ripening at large levels of supersaturation |
| CA2642504A1 (en) | 2006-03-14 | 2007-09-20 | Brian K. Johnson | Processes and apparatuses for the production of crystalline organic microparticle compositions by micro-milling and crystallization on micro-seed and their use |
| WO2008041176A2 (en) * | 2006-10-03 | 2008-04-10 | Ranbaxy Laboratories Limited | Process for the preparation of form i and form ii of ritonavir |
| EP2050437A1 (en) * | 2007-10-15 | 2009-04-22 | Laboratoires SMB | Improved pharmaceutical dry powder compositions for inhalation. |
| WO2009074666A1 (en) | 2007-12-13 | 2009-06-18 | Novartis Ag | Organic compounds |
| PT105058B (pt) * | 2010-04-21 | 2013-04-17 | Hovione Farmaciencia S A | Processo para processamento de partículas de ingredientes activos farmacêuticos |
| PT106237B (pt) * | 2012-03-30 | 2015-03-19 | Hovione Farmaci Ncia S A | Produção de partículas substancialmente monodispersas utilizando moagem e separação por membranas |
-
2014
- 2014-01-28 PT PT10743314A patent/PT107433B/pt active IP Right Grant
-
2015
- 2015-01-27 JP JP2016549143A patent/JP6499187B2/ja not_active Expired - Fee Related
- 2015-01-27 DK DK15702834.1T patent/DK3096738T3/en active
- 2015-01-27 ES ES15702834T patent/ES2702643T3/es active Active
- 2015-01-27 EP EP15702834.1A patent/EP3096738B1/en not_active Not-in-force
- 2015-01-27 US US15/115,193 patent/US10328027B2/en not_active Expired - Fee Related
- 2015-01-27 WO PCT/GB2015/050186 patent/WO2015114320A1/en not_active Ceased
- 2015-01-27 CA CA2938071A patent/CA2938071A1/en not_active Abandoned
- 2015-01-27 HU HUE15702834A patent/HUE041329T2/hu unknown
- 2015-01-27 AU AU2015212618A patent/AU2015212618B2/en not_active Ceased
-
2016
- 2016-07-28 IL IL246989A patent/IL246989A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3096738A1 (en) | 2016-11-30 |
| AU2015212618B2 (en) | 2018-08-02 |
| EP3096738B1 (en) | 2018-09-26 |
| JP6499187B2 (ja) | 2019-04-10 |
| WO2015114320A1 (en) | 2015-08-06 |
| US10328027B2 (en) | 2019-06-25 |
| JP2017504637A (ja) | 2017-02-09 |
| PT107433A (pt) | 2015-07-28 |
| CA2938071A1 (en) | 2015-08-06 |
| PT107433B (pt) | 2018-12-04 |
| IL246989A0 (en) | 2016-09-29 |
| US20160346206A1 (en) | 2016-12-01 |
| ES2702643T3 (es) | 2019-03-04 |
| AU2015212618A1 (en) | 2016-09-15 |
| DK3096738T3 (en) | 2019-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL246989A0 (en) | A controlled process to reduce particle size | |
| GB201405614D0 (en) | Particles | |
| GB201413701D0 (en) | Process | |
| GB201417076D0 (en) | Process | |
| GB201405800D0 (en) | Process | |
| GB201405210D0 (en) | Process | |
| GB201504782D0 (en) | Process | |
| GB201415862D0 (en) | Process | |
| GB201404468D0 (en) | Process | |
| GB201413340D0 (en) | Process | |
| GB201412841D0 (en) | Particles | |
| GB201402950D0 (en) | Process | |
| GB2524136B (en) | Process | |
| GB201420285D0 (en) | Process | |
| GB201409126D0 (en) | Process | |
| GB201400137D0 (en) | Process | |
| GB201412406D0 (en) | Process | |
| SG11201703003VA (en) | Process | |
| GB201414292D0 (en) | Process | |
| GB201411627D0 (en) | Process | |
| GB2538692B (en) | Process | |
| SG11201610471UA (en) | Process | |
| GB201415972D0 (en) | Process | |
| GB201412656D0 (en) | Process | |
| GB201410174D0 (en) | Process |